Negócios · 21/12/19981 min de leitura
Oral Dosage Form New Animal Drugs; Oxytetracycline Tablet/Bolus
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Boehringer Ingelheim Vetmedica, Inc. The NADA provides for use of oxytetracycline boluses for control and treatment of bacterial enteritis and bacterial pneumonia in beef and dairy calves.